F
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- SC 13G/A51.2 KBFuriex Pharmaceuticals, Inc.Feb 17, 4:27 PM ET·0001144204-15-010162
- SC 13G/A39.8 KBFuriex Pharmaceuticals, Inc.Feb 17, 1:31 PM ET·0001085146-15-000686
- SC 13G/A13.8 KBFuriex Pharmaceuticals, Inc.Feb 6, 3:01 PM ET·0001008322-15-000016
- SC 13D/A93.1 KBFuriex Pharmaceuticals, Inc.Jul 8, 8:41 PM ET·0001193125-14-263381
- 411.8 KBFuriex Pharmaceuticals, Inc.Jul 7, 8:49 PM ET·0001209191-14-046288
- SC 13D110.4 KBFuriex Pharmaceuticals, Inc.Jul 7, 5:11 PM ET·0001193125-14-262058
- 414.5 KBFuriex Pharmaceuticals, Inc.Jul 7, 4:40 PM ET·0001437749-14-012512
- 412.0 KBFuriex Pharmaceuticals, Inc.Jul 7, 4:39 PM ET·0001437749-14-012511
- 49.9 KBFuriex Pharmaceuticals, Inc.Jul 7, 4:39 PM ET·0001437749-14-012510
- 413.7 KBFuriex Pharmaceuticals, Inc.Jul 7, 4:39 PM ET·0001437749-14-012509
Insiders
10- Allergan plc10% Owner
- Almenoff June SherieDirector, President
- Artal Group S.A.Director, 10% Owner
- Artal International S.C.A.Director, 10% Owner
- BONDURANT STUARTDirector
- CORR PETER BDirector
- COVINGTON PAUL SSenior VP-Clinical Operations
- DAVIS STEPHENDirector
- DIXON WENDY LDirector
- ESHELMAN FREDRIC NDirector, 10% Owner
Tickers
No tickers on record
Addresses
business
3900 PARAMOUNT PARKWAY SUITE 150
MORRISVILLE, NC, 27560
mailing
3900 PARAMOUNT PARKWAY SUITE 150
MORRISVILLE, NC, 27560